Paul Ashton talks about the innovation within pSivida and its early stage work on proteins.

pSivida has developed 3 of the 4 sustained delivery systems for the vitreous and retina that have been approved either in the US or the EU


Paul Ashton

Paul Ashton

Dr. Ashton has over 25 years experience in drug delivery. He has invented and developed (with colleagues) Vitrasert (the first intravitreal drug delivery system to be approved by the FDA), Retisert (first FDA approved product for uveitis) and Iluvien (first sustained release product for DME approved in EU).

View Full Profile